Derrick J. Rossi
Founder at Stelexis Therapeutics LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Lewin | M | - |
Ophirex, Inc.
 Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | - |
| Drew Adams | M | - |
Convelo Therapeutics, Inc.
 Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | 8 years |
| Maurie Perl | F | - |
New York Stem Cell Foundation, Inc.
| 9 years |
| Jerry D. Harrison | M | - |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | - |
| Nancy J. Koch | F | - |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | - |
| Paul Tesar | M | 36 |
Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | 8 years |
| Ulrich Steidl | M | - |
Stelexis Therapeutics LLC
 Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | 7 years |
| Alan M. Cohen | M | 73 |
New York Stem Cell Foundation, Inc.
| - |
| Daniel Paull | M | - |
New York Stem Cell Foundation, Inc.
| - |
| Katie Krumholz | F | - |
New York Stem Cell Foundation, Inc.
| - |
| Cindy Anzel | F | - |
New York Stem Cell Foundation, Inc.
| - |
| Michael Zdanowski | M | 57 |
New York Stem Cell Foundation, Inc.
| - |
| Roy G. Geronemus | M | - |
New York Stem Cell Foundation, Inc.
| - |
| Bob Jackson | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Mark Shtilerman | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Bill Sanford | M | 80 |
Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | - |
| Stephen Scherr | M | 59 |
New York Stem Cell Foundation, Inc.
| - |
| Peter W. Steelman | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Timothy Garnett | M | 63 |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | - |
| Hans Bishop | M | 59 |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | 4 years |
| Patrick James Doyle | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Jarmo Heiniö | M | 76 |
University of Helsinki
| 22 years |
| Curt LaBelle | M | 53 |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | - |
| Ronald Richard | M | 68 |
Convelo Therapeutics, Inc.
Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | - |
| Paul Meister | M | 71 |
New York Stem Cell Foundation, Inc.
| - |
| Nachi Gupta | M | - |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen M. Chang | M | 68 |
New York Stem Cell Foundation, Inc.
| - |
| Antti William Uusiheimala | M | - |
University of Helsinki
| 3 years |
| Max Johan Casper Herler | M | - |
University of Helsinki
| 3 years |
| Marjo Nurmi | F | 49 |
University of Helsinki
| 5 years |
| Lisa Shapiro Strovink | F | - |
New York Stem Cell Foundation, Inc.
| 4 years |
| Evripidis Gavathiotis | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Amit Verma | M | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | - |
| Tae-Seung Son | M | 65 |
University of Helsinki
| 1 years |
| Esa Ville Ilmari Niinimäki | M | 48 |
University of Helsinki
| 3 years |
| Wilhelm Valdemar Lindholm | M | - |
University of Helsinki
| 5 years |
| Lasse Ilmari Laaksonen | M | - |
University of Helsinki
| 3 years |
| Jani Rautiainen | M | - |
University of Helsinki
| 6 years |
| Jani Rantanen | M | - |
University of Helsinki
| 1 years |
| Ki Youl Suh | M | - |
University of Helsinki
| 2 years |
| Jeom-Ju Kwon | M | 69 |
University of Helsinki
| 2 years |
| Jukka Manner | M | 52 |
University of Helsinki
| 3 years |
| Jyri Engeström | M | - |
University of Helsinki
| 5 years |
| W. Oh | M | - |
University of Helsinki
| 2 years |
| Antti Palmujoki | M | - |
University of Helsinki
| 3 years |
| Martti Sakari Vaara | M | - |
University of Helsinki
| 3 years |
| Atte Kustaa Piha | M | - |
University of Helsinki
| 3 years |
| Walter Swanljung | M | - |
University of Helsinki
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 60.42% |
| Finland | 19 | 39.58% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Derrick J. Rossi
- Personal Network
